Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Guggenheim analyst Yatin Suneja initiates coverage on Oruka Therapeutics (NASDAQ:ORKA) with a Buy rating and announces Price...
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Oruka Therapeutics (NASDAQ:ORKA) with a Buy and lowers the pric...
Barclays analyst Etzer Darout initiates coverage on Oruka Therapeutics (NASDAQ:ORKA) with a Overweight rating and announces ...
Editor’s Note: The future prices of benchmark tracking ETFs were updated in the story. U.S. stock futures rose on Monday fol...
US stock futures up, focus on Constellation Brands, SkyWater Tech, Aehr Test Systems, Oruka Therapeutics and VCI Global earnings.
https://www.sec.gov/Archives/edgar/data/907654/000121390025096198/ea0260073-s3_oruka.htm
BTIG analyst Julian Harrison reiterates Oruka Therapeutics (NASDAQ: ORKA) with a Buy and maintains $56 price target.
